Industry Research Reports

Home > Reports > Medical Care > Bispecific and Trispecific Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Bispecific and Trispecific Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-11

Pages: 124 Pages

Report ld: 2639017

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Bispecific and Trispecific Antibody was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Bispecific and Trispecific Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Bispecific and Trispecific Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Bispecific and Trispecific Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Bispecific and Trispecific Antibody include AbbVie, Affimed, Biotheus, Biontech, Genmab, GT Biopharma, Harpoon Therapeutics, MacroGenics and Numab, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bispecific and Trispecific Antibody, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bispecific and Trispecific Antibody by region & country, by Type, and by Application.

The Bispecific and Trispecific Antibody market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific and Trispecific Antibody.

Market Segmentation

Report Metric
Details
Report Title
Bispecific and Trispecific Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Bispecific and Trispecific Antibody Companies Covered
AbbVie, Affimed, Biotheus, Biontech, Genmab, GT Biopharma, Harpoon Therapeutics, MacroGenics, Numab, Sanofi, Sichuan Baili Pharmaceuticals, Roche, Amgen, Pfizer, Johnson & Johnson, AstraZeneca
Global Bispecific and Trispecific Antibody Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bispecific and Trispecific Antibody Market, Segment by Type
Bispecific Antibody

Trispecific Antibody
Global Bispecific and Trispecific Antibody Market, Segment by Application
Cancer

Haemophilia

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bispecific and Trispecific Antibody manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Bispecific and Trispecific Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Bispecific and Trispecific Antibody in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Bispecific and Trispecific Antibody Product Introduction
    1.2 Global Bispecific and Trispecific Antibody Market Size Forecast
    1.3 Bispecific and Trispecific Antibody Market Trends & Drivers
        1.3.1 Bispecific and Trispecific Antibody Industry Trends
        1.3.2 Bispecific and Trispecific Antibody Market Drivers & Opportunity
        1.3.3 Bispecific and Trispecific Antibody Market Challenges
        1.3.4 Bispecific and Trispecific Antibody Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Bispecific and Trispecific Antibody Players Revenue Ranking (2023)
    2.2 Global Bispecific and Trispecific Antibody Revenue by Company (2019-2024)
    2.3 Key Companies Bispecific and Trispecific Antibody Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Bispecific and Trispecific Antibody Product Offered
    2.5 Key Companies Time to Begin Mass Production of Bispecific and Trispecific Antibody
    2.6 Bispecific and Trispecific Antibody Market Competitive Analysis
        2.6.1 Bispecific and Trispecific Antibody Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Bispecific and Trispecific Antibody Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific and Trispecific Antibody as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Bispecific Antibody
        3.1.2 Trispecific Antibody
    3.2 Global Bispecific and Trispecific Antibody Sales Value by Type
        3.2.1 Global Bispecific and Trispecific Antibody Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Bispecific and Trispecific Antibody Sales Value, by Type (2019-2030)
        3.2.3 Global Bispecific and Trispecific Antibody Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Cancer
        4.1.2 Haemophilia
        4.1.3 Others
    4.2 Global Bispecific and Trispecific Antibody Sales Value by Application
        4.2.1 Global Bispecific and Trispecific Antibody Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Bispecific and Trispecific Antibody Sales Value, by Application (2019-2030)
        4.2.3 Global Bispecific and Trispecific Antibody Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Bispecific and Trispecific Antibody Sales Value by Region
        5.1.1 Global Bispecific and Trispecific Antibody Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Bispecific and Trispecific Antibody Sales Value by Region (2019-2024)
        5.1.3 Global Bispecific and Trispecific Antibody Sales Value by Region (2025-2030)
        5.1.4 Global Bispecific and Trispecific Antibody Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Bispecific and Trispecific Antibody Sales Value, 2019-2030
        5.2.2 North America Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Bispecific and Trispecific Antibody Sales Value, 2019-2030
        5.3.2 Europe Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Bispecific and Trispecific Antibody Sales Value, 2019-2030
        5.4.2 Asia Pacific Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Bispecific and Trispecific Antibody Sales Value, 2019-2030
        5.5.2 South America Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Bispecific and Trispecific Antibody Sales Value, 2019-2030
        5.6.2 Middle East & Africa Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Bispecific and Trispecific Antibody Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Bispecific and Trispecific Antibody Sales Value
    6.3 United States
        6.3.1 United States Bispecific and Trispecific Antibody Sales Value, 2019-2030
        6.3.2 United States Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Bispecific and Trispecific Antibody Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Bispecific and Trispecific Antibody Sales Value, 2019-2030
        6.4.2 Europe Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Bispecific and Trispecific Antibody Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Bispecific and Trispecific Antibody Sales Value, 2019-2030
        6.5.2 China Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Bispecific and Trispecific Antibody Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Bispecific and Trispecific Antibody Sales Value, 2019-2030
        6.6.2 Japan Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Bispecific and Trispecific Antibody Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Bispecific and Trispecific Antibody Sales Value, 2019-2030
        6.7.2 South Korea Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Bispecific and Trispecific Antibody Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Bispecific and Trispecific Antibody Sales Value, 2019-2030
        6.8.2 Southeast Asia Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Bispecific and Trispecific Antibody Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Bispecific and Trispecific Antibody Sales Value, 2019-2030
        6.9.2 India Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Bispecific and Trispecific Antibody Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 AbbVie
        7.1.1 AbbVie Profile
        7.1.2 AbbVie Main Business
        7.1.3 AbbVie Bispecific and Trispecific Antibody Products, Services and Solutions
        7.1.4 AbbVie Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.1.5 AbbVie Recent Developments
    7.2 Affimed
        7.2.1 Affimed Profile
        7.2.2 Affimed Main Business
        7.2.3 Affimed Bispecific and Trispecific Antibody Products, Services and Solutions
        7.2.4 Affimed Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.2.5 Affimed Recent Developments
    7.3 Biotheus
        7.3.1 Biotheus Profile
        7.3.2 Biotheus Main Business
        7.3.3 Biotheus Bispecific and Trispecific Antibody Products, Services and Solutions
        7.3.4 Biotheus Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.3.5 Biontech Recent Developments
    7.4 Biontech
        7.4.1 Biontech Profile
        7.4.2 Biontech Main Business
        7.4.3 Biontech Bispecific and Trispecific Antibody Products, Services and Solutions
        7.4.4 Biontech Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.4.5 Biontech Recent Developments
    7.5 Genmab
        7.5.1 Genmab Profile
        7.5.2 Genmab Main Business
        7.5.3 Genmab Bispecific and Trispecific Antibody Products, Services and Solutions
        7.5.4 Genmab Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.5.5 Genmab Recent Developments
    7.6 GT Biopharma
        7.6.1 GT Biopharma Profile
        7.6.2 GT Biopharma Main Business
        7.6.3 GT Biopharma Bispecific and Trispecific Antibody Products, Services and Solutions
        7.6.4 GT Biopharma Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.6.5 GT Biopharma Recent Developments
    7.7 Harpoon Therapeutics
        7.7.1 Harpoon Therapeutics Profile
        7.7.2 Harpoon Therapeutics Main Business
        7.7.3 Harpoon Therapeutics Bispecific and Trispecific Antibody Products, Services and Solutions
        7.7.4 Harpoon Therapeutics Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.7.5 Harpoon Therapeutics Recent Developments
    7.8 MacroGenics
        7.8.1 MacroGenics Profile
        7.8.2 MacroGenics Main Business
        7.8.3 MacroGenics Bispecific and Trispecific Antibody Products, Services and Solutions
        7.8.4 MacroGenics Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.8.5 MacroGenics Recent Developments
    7.9 Numab
        7.9.1 Numab Profile
        7.9.2 Numab Main Business
        7.9.3 Numab Bispecific and Trispecific Antibody Products, Services and Solutions
        7.9.4 Numab Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.9.5 Numab Recent Developments
    7.10 Sanofi
        7.10.1 Sanofi Profile
        7.10.2 Sanofi Main Business
        7.10.3 Sanofi Bispecific and Trispecific Antibody Products, Services and Solutions
        7.10.4 Sanofi Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.10.5 Sanofi Recent Developments
    7.11 Sichuan Baili Pharmaceuticals
        7.11.1 Sichuan Baili Pharmaceuticals Profile
        7.11.2 Sichuan Baili Pharmaceuticals Main Business
        7.11.3 Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Products, Services and Solutions
        7.11.4 Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.11.5 Sichuan Baili Pharmaceuticals Recent Developments
    7.12 Roche
        7.12.1 Roche Profile
        7.12.2 Roche Main Business
        7.12.3 Roche Bispecific and Trispecific Antibody Products, Services and Solutions
        7.12.4 Roche Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.12.5 Roche Recent Developments
    7.13 Amgen
        7.13.1 Amgen Profile
        7.13.2 Amgen Main Business
        7.13.3 Amgen Bispecific and Trispecific Antibody Products, Services and Solutions
        7.13.4 Amgen Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.13.5 Amgen Recent Developments
    7.14 Pfizer
        7.14.1 Pfizer Profile
        7.14.2 Pfizer Main Business
        7.14.3 Pfizer Bispecific and Trispecific Antibody Products, Services and Solutions
        7.14.4 Pfizer Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.14.5 Pfizer Recent Developments
    7.15 Johnson & Johnson
        7.15.1 Johnson & Johnson Profile
        7.15.2 Johnson & Johnson Main Business
        7.15.3 Johnson & Johnson Bispecific and Trispecific Antibody Products, Services and Solutions
        7.15.4 Johnson & Johnson Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.15.5 Johnson & Johnson Recent Developments
    7.16 AstraZeneca
        7.16.1 AstraZeneca Profile
        7.16.2 AstraZeneca Main Business
        7.16.3 AstraZeneca Bispecific and Trispecific Antibody Products, Services and Solutions
        7.16.4 AstraZeneca Bispecific and Trispecific Antibody Revenue (US$ Million) & (2019-2024)
        7.16.5 AstraZeneca Recent Developments

 8 Industry Chain Analysis
    8.1 Bispecific and Trispecific Antibody Industrial Chain
    8.2 Bispecific and Trispecific Antibody Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Bispecific and Trispecific Antibody Sales Model
        8.5.2 Sales Channel
        8.5.3 Bispecific and Trispecific Antibody Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Bispecific and Trispecific Antibody Market Trends
    Table 2. Bispecific and Trispecific Antibody Market Drivers & Opportunity
    Table 3. Bispecific and Trispecific Antibody Market Challenges
    Table 4. Bispecific and Trispecific Antibody Market Restraints
    Table 5. Global Bispecific and Trispecific Antibody Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Bispecific and Trispecific Antibody Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Bispecific and Trispecific Antibody Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Bispecific and Trispecific Antibody Product Type
    Table 9. Key Companies Time to Begin Mass Production of Bispecific and Trispecific Antibody
    Table 10. Global Bispecific and Trispecific Antibody Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific and Trispecific Antibody as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Bispecific and Trispecific Antibody Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Bispecific and Trispecific Antibody Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Bispecific and Trispecific Antibody Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Bispecific and Trispecific Antibody Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Bispecific and Trispecific Antibody Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Bispecific and Trispecific Antibody Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Bispecific and Trispecific Antibody Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Bispecific and Trispecific Antibody Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Bispecific and Trispecific Antibody Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Bispecific and Trispecific Antibody Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Bispecific and Trispecific Antibody Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Bispecific and Trispecific Antibody Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Bispecific and Trispecific Antibody Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Bispecific and Trispecific Antibody Sales Value by Region (2019-2024) & (%)
    Table 27. Global Bispecific and Trispecific Antibody Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Bispecific and Trispecific Antibody Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Bispecific and Trispecific Antibody Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Bispecific and Trispecific Antibody Sales Value, (2025-2030) & (US$ Million)
    Table 31. AbbVie Basic Information List
    Table 32. AbbVie Description and Business Overview
    Table 33. AbbVie Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of AbbVie (2019-2024)
    Table 35. AbbVie Recent Developments
    Table 36. Affimed Basic Information List
    Table 37. Affimed Description and Business Overview
    Table 38. Affimed Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Affimed (2019-2024)
    Table 40. Affimed Recent Developments
    Table 41. Biotheus Basic Information List
    Table 42. Biotheus Description and Business Overview
    Table 43. Biotheus Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Biotheus (2019-2024)
    Table 45. Biotheus Recent Developments
    Table 46. Biontech Basic Information List
    Table 47. Biontech Description and Business Overview
    Table 48. Biontech Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Biontech (2019-2024)
    Table 50. Biontech Recent Developments
    Table 51. Genmab Basic Information List
    Table 52. Genmab Description and Business Overview
    Table 53. Genmab Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Genmab (2019-2024)
    Table 55. Genmab Recent Developments
    Table 56. GT Biopharma Basic Information List
    Table 57. GT Biopharma Description and Business Overview
    Table 58. GT Biopharma Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of GT Biopharma (2019-2024)
    Table 60. GT Biopharma Recent Developments
    Table 61. Harpoon Therapeutics Basic Information List
    Table 62. Harpoon Therapeutics Description and Business Overview
    Table 63. Harpoon Therapeutics Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Harpoon Therapeutics (2019-2024)
    Table 65. Harpoon Therapeutics Recent Developments
    Table 66. MacroGenics Basic Information List
    Table 67. MacroGenics Description and Business Overview
    Table 68. MacroGenics Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of MacroGenics (2019-2024)
    Table 70. MacroGenics Recent Developments
    Table 71. Numab Basic Information List
    Table 72. Numab Description and Business Overview
    Table 73. Numab Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Numab (2019-2024)
    Table 75. Numab Recent Developments
    Table 76. Sanofi Basic Information List
    Table 77. Sanofi Description and Business Overview
    Table 78. Sanofi Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Sanofi (2019-2024)
    Table 80. Sanofi Recent Developments
    Table 81. Sichuan Baili Pharmaceuticals Basic Information List
    Table 82. Sichuan Baili Pharmaceuticals Description and Business Overview
    Table 83. Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Sichuan Baili Pharmaceuticals (2019-2024)
    Table 85. Sichuan Baili Pharmaceuticals Recent Developments
    Table 86. Roche Basic Information List
    Table 87. Roche Description and Business Overview
    Table 88. Roche Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Roche (2019-2024)
    Table 90. Roche Recent Developments
    Table 91. Amgen Basic Information List
    Table 92. Amgen Description and Business Overview
    Table 93. Amgen Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Amgen (2019-2024)
    Table 95. Amgen Recent Developments
    Table 96. Pfizer Basic Information List
    Table 97. Pfizer Description and Business Overview
    Table 98. Pfizer Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Pfizer (2019-2024)
    Table 100. Pfizer Recent Developments
    Table 101. Johnson & Johnson Basic Information List
    Table 102. Johnson & Johnson Description and Business Overview
    Table 103. Johnson & Johnson Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of Johnson & Johnson (2019-2024)
    Table 105. Johnson & Johnson Recent Developments
    Table 106. AstraZeneca Basic Information List
    Table 107. AstraZeneca Description and Business Overview
    Table 108. AstraZeneca Bispecific and Trispecific Antibody Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Bispecific and Trispecific Antibody Business of AstraZeneca (2019-2024)
    Table 110. AstraZeneca Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Bispecific and Trispecific Antibody Downstream Customers
    Table 114. Bispecific and Trispecific Antibody Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Bispecific and Trispecific Antibody Product Picture
    Figure 2. Global Bispecific and Trispecific Antibody Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bispecific and Trispecific Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 4. Bispecific and Trispecific Antibody Report Years Considered
    Figure 5. Global Bispecific and Trispecific Antibody Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Bispecific and Trispecific Antibody Revenue in 2023
    Figure 7. Bispecific and Trispecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Bispecific Antibody Picture
    Figure 9. Trispecific Antibody Picture
    Figure 10. Global Bispecific and Trispecific Antibody Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Bispecific and Trispecific Antibody Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Cancer
    Figure 13. Product Picture of Haemophilia
    Figure 14. Product Picture of Others
    Figure 15. Global Bispecific and Trispecific Antibody Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Bispecific and Trispecific Antibody Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Bispecific and Trispecific Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Bispecific and Trispecific Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Bispecific and Trispecific Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Bispecific and Trispecific Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Bispecific and Trispecific Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Bispecific and Trispecific Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Bispecific and Trispecific Antibody Sales Value (%), (2019-2030)
    Figure 28. United States Bispecific and Trispecific Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Bispecific and Trispecific Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Bispecific and Trispecific Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Bispecific and Trispecific Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Bispecific and Trispecific Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Bispecific and Trispecific Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Bispecific and Trispecific Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Bispecific and Trispecific Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Bispecific and Trispecific Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Bispecific and Trispecific Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Bispecific and Trispecific Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Bispecific and Trispecific Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Bispecific and Trispecific Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Bispecific and Trispecific Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Bispecific and Trispecific Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 49. Bispecific and Trispecific Antibody Industrial Chain
    Figure 50. Bispecific and Trispecific Antibody Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation

Description

The global market for Bispecific and Trispecific Antibody was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Bispecific and Trispecific Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Bispecific and Trispecific Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Bispecific and Trispecific Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Bispecific and Trispecific Antibody include AbbVie, Affimed, Biotheus, Biontech, Genmab, GT Biopharma, Harpoon Therapeutics, MacroGenics and Numab, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bispecific and Trispecific Antibody, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bispecific and Trispecific Antibody by region & country, by Type, and by Application.

The Bispecific and Trispecific Antibody market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific and Trispecific Antibody.

Market Segmentation